Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Constipation after starting Wegovy is common and usually manageable at home with hydration, fiber, and gentle exercise. Use this quick checklist to tell routine symptoms from red flags:
Routine (manage at home):
Red flags (seek medical care):
See below for the full checklist and detailed guidance on when to treat at home versus when to seek medical attention.
Because Wegovy-related constipation can overlap with more serious GI issues, it's worth getting personalized insight into your symptoms. Take this free, instant, online symptom check to better understand what's going on and confidently navigate your next steps.
Reviewed for medical accuracy: 07/10/2026
Quick answers
The most common questions people search after this page
Many people experience Wegovy constipation after starting therapy. Wegovy (semaglutide) is a GLP-1 receptor agonist approved for weight management. While it can help curb appetite and slow gastric emptying, this very effect can lead to constipation. In most cases, milder symptoms improve with simple measures—but you'll want to know when to treat at home and when to seek medical attention.
Wegovy works by:
These actions can lead to firmer stools, less frequent bowel movements, and a feeling of blockage. Symptoms often appear in the first few weeks as your body adjusts, then stabilize or improve over time.
Use the following checklist to gauge whether your Wegovy-related constipation is mild or warrants medical evaluation:
If you notice any red-flag symptoms, take them seriously. They could indicate a bowel obstruction, impaction, or a separate digestive issue requiring prompt attention.
Most cases of mild to moderate Wegovy constipation can be managed at home. Try these evidence-backed tips:
Always start with the lowest effective dose. If you're unsure which product suits you best, consult a pharmacist.
While mild discomfort often resolves, persistent or severe issues require professional evaluation. Contact your healthcare provider or speak to a doctor if you experience:
If any symptom feels life threatening—sudden severe pain, persistent vomiting, confusion, rapid heartbeat—head to the nearest emergency department.
Not sure if your digestive symptoms need immediate attention? Use Ubie's free AI symptom checker to get personalized guidance on whether your condition can be managed at home or requires a doctor's visit.
Once you've gotten through the initial adjustment period, sustain healthy habits to minimize recurrence:
Wegovy constipation after starting therapy is common and often temporary. Use the checklist to distinguish mild symptoms from red flags, implement lifestyle and OTC measures, and seek help if severe or prolonged issues arise. Remember, prompt action can prevent complications.
If you have any serious concerns—or if constipation is accompanied by severe pain, vomiting, or other alarming signs—please speak to a doctor right away. Your health and peace of mind are worth it.
(References)
* Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. PMID: 33567185.
* Singh G, D'Souza D, Kumar S, et al. Adverse Events Associated With Semaglutide: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 May 2;5(5):e2213710. doi: 10.1001/jamanetworkopen.2022.13710. PMID: 35503460; PMCID: PMC9065969.
* Chang L, Chey WD, Lembo AJ, et al. A review of the effects of glucagon-like peptide-1 receptor agonists on gastrointestinal motility and their potential relevance to gastrointestinal symptoms. Neurogastroenterol Motil. 2021 Jul;33(7):e14088. doi: 10.1111/nmo.14088. Epub 2021 Mar 22. PMID: 33754298.
* Früh M, Baumgartner H, Kaser S, et al. Real-world safety and tolerability of semaglutide and dulaglutide for type 2 diabetes management: a pooled analysis. Diabetes Res Clin Pract. 2023 Apr;200:110706. doi: 10.1016/j.diabres.2023.110706. Epub 2023 Feb 28. PMID: 36863489.
* Mishra R, Kumar A, Kumar P, Singh V, Agrawal S. Gastrointestinal Adverse Events Associated With Semaglutide: A Systematic Review. J Clin Pharmacol. 2024 Jan;64(1):23-32. doi: 10.1002/jcph.2343. Epub 2023 Oct 12. PMID: 37827917.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.